In terms of value, the Elastomeric Infusion Pumps Market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3%, as per the recent study by MarketsandMarkets™.
InfuSystem Holdings gains from NOPAIN ACT reimbursements as net income growth outpaces peers and revenue rebounds. Check out ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global programmable infusion pumps market and the market is poised to grow by USD 487.81 million during 2020-2024 at a CAGR of almost 8% ...
For the third time in the last two years, Baxter has been hit with the FDA’s most serious label for a recall affecting its infusion pump systems. This time around, the Class I recall notice is linked ...
The global elastomeric infusion pumps growth is driven by rising demand for home-based care, ambulatory treatment, and ...
Infusion pump systems are some of the most widely utilized devices in hospitals. Robert Canfield, Director of Marketing for infusion systems at Fresenius Kabi, said that the capabilities of these ...
You've probably seen an infusion pump, even though the name might make it sound like a mysterious piece of medical technology. These devices govern the flow of IV medications and fluids into patients.
This tutorial discusses critical considerations requiring attention when designing an infusion pump, including FDA regulation, self-test circuitry, and meeting the IEC 60601-1 standard for electrical ...
The US Food and Drug Administration (FDA) has received reports of serious adverse events, including patient injury and death, associated with the use of implantable infusion pumps in the magnetic ...
Infusion pumps have been plagued with multiple FDA recalls in recent years, and some of the pumps identified in the recalls are still in use, according to a report by DotMed. For example, 200,000 ...
In its second safety alert this year, Smiths Medical has issued a letter to its customers detailing a pair of potential issues with the infusion sets used alongside its CADD line of infusion systems.
Zacks Investment Research on MSN
Reasons to retain Baxter International stock in your portfolio now
Baxter International BAX is currently in transition following the divestiture of Kidney Care, balancing near-term execution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results